Riskpilot← Back to searchSign inGet full accessBIOFAC A/S
A/SActiveCVR 62550511Englandsvej 350-356Manufacture of basic pharmaceutical products · NACE 2110Est. 193487 employees
Revenue 2025
DKK 73,6M
+12% vs 2024
EBITDA margin
3.9%
-67% vs 2024
Equity ratio
7.2%
Financial strength
Net profit 2025
DKK -3,8M
-1236% vs 2024
| Revenue | DKK 73,6M | +12% |
| EBITDA | DKK 2,9M | -67% |
| Net profit | DKK -3,8M | -1236% |
| Total assets | DKK 151,2M | -6% |
| Equity | DKK 10,8M | -26% |
| Employees | 87 | — |
Legal name
BIOFAC A/S
CVR number
62550511
Legal form
Aktieselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
17. november 1934
Share capital
DKK 1.000.000
Employees
87 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør eller af 1 bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive industri og handel eller dermed beslægtet virksomhed efter bestyrelsens skøn såvel i ind- som i udland
Address
Englandsvej 350-356
Phone
+4570103020
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.449 | 40.643 | 44.369 | 44.175 | 54.950 | 16.448 | 14.400 | 23.387 | 28.824 | 20.289 | 37.268 | 65.665 | 73.647 |
| Staff expenses | -11.898 | -13.032 | -16.030 | -16.481 | -18.951 | -20.181 | -19.478 | -23.306 | -24.584 | -23.492 | -27.755 | -56.981 | -60.813 |
| EBITDA | 1.762 | 3.840 | -407 | 3.163 | 792 | -3.733 | -5.078 | 81 | 4.240 | -3.203 | 9.513 | 8.685 | 2.872 |
| Depreciation & amort. | -2.238 | -2.895 | -2.751 | -3.127 | -4.697 | -4.378 | -4.872 | -4.285 | -3.875 | -3.076 | -3.048 | -3.505 | -3.308 |
| EBIT | -476 | 945 | -3.159 | 36 | -3.905 | -8.111 | -9.950 | -4.204 | 366 | -6.279 | 6.465 | 5.180 | -436 |
| Net financials | -1.787 | -1.787 | 8.851 | -1.249 | -987 | -1.216 | -251 | -1.172 | -1.784 | -1.325 | -4.402 | -4.750 | -4.187 |
| Profit before tax | -2.263 | -842 | 5.692 | -1.213 | -4.892 | -9.327 | -10.201 | -5.376 | -1.418 | -7.604 | 2.063 | 430 | -4.623 |
| Tax | -615 | -423 | 1.329 | -279 | -1.076 | -2.051 | -2.251 | -1.183 | -283 | -1.651 | 454 | 98 | -847 |
| Net profit | -1.647 | -419 | 4.364 | -934 | -3.816 | -7.276 | -7.950 | -4.193 | -1.135 | -5.953 | 1.610 | 333 | -3.776 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 99.272 | 100.222 | 116.078 | 131.098 | 148.872 | 163.603 | 167.293 | 164.460 | 161.491 | 142.566 | 156.736 | 161.331 | 151.156 |
| Equity | 9.728 | 9.059 | 11.872 | 10.287 | 4.151 | 11.875 | 23.925 | 19.732 | 18.597 | 12.644 | 14.254 | 14.586 | 10.810 |
| Long-term debt | 37.846 | 36.264 | 33.412 | 31.835 | 30.195 | 374 | 281 | 183 | 80 | 0 | 0 | 0 | 0 |
| Short-term debt | 49.805 | 51.321 | 67.548 | 87.071 | 110.754 | 146.090 | 137.763 | 140.224 | 137.268 | 125.609 | 137.785 | 142.018 | 136.897 |
| Total debt | 87.651 | 87.584 | 100.961 | 118.905 | 140.949 | 146.464 | 138.043 | 140.407 | 137.348 | 125.609 | 137.785 | 142.018 | 136.897 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20132025
Equity ratio
7.2%
This company
38.2%
Market median
-81% vs market
20132025
Return on equity
-34.9%
This company
18.4%
Market median
-290% vs market
20132025
Net profit margin
-5.1%
This company
8.1%
Market median
-163% vs market
20132025
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20132025
Debt / equity
12.98×
This company
0.62×
Market median
-1994% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NO Management | Management | 1934 | — | — |
PR Management | Management | 1934 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1934 | — | — | |
| Board of Directors | 1934 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 1934 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 1998 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
H&P Rørvig Holding A/S | Company | 100.0% | 100.0% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
H&P Rørvig Holding A/S
BIOFAC A/S Board members of BIOFAC A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Otto Thiesen | Management | 0 companies |
| Peter Rørvig | Management | 0 companies |
| Ludmilla Tamara Dorothea Thiesen | Board of Directors | 0 companies |
| Lore Rørvig | Board of Directors | 0 companies |
| Svend Blankholm | Board of Directors | 0 companies |
| Erik Vilhelm Balslev | Board of Directors | 0 companies |
| Helle Rørvig | Board of Directors | 0 companies |
| Niels Ulrik Heine | Board of Directors | 0 companies |